Hot Topics

Poll

Why is it a big mistake to link funding of R&D costs with drug prices?:

WIPO patent committee (SCP21): Intervention of KEI on Patents and Health

The following intervention on patents and health was delivered by KEI during the 21st session on WIPO's Standing Committee on the Law of Patents (SCP). Part 1 was delivered on 4 November 2014 during discussions of the Feasibility Study on the Disclosure of International Nonproprietary Names (INN) in Patent Applications and/or Patents. Part 2 was delivered on 5 November 2014 during general discussions on patents and health.

Statement of Knowledge Ecology International (KEI)

Item 7: Patents and health

Part 1

WIPO patent committee (SCP21): Intervention of Pakistan on Patents and Health

On Wednesday, 5 November 2014, Pakistan delivered the following intervention on patents and health.

Agenda 7 Statement on patents and health

1. General statement

Mr. Chair,

I will make this statement in national capacity,

WIPO Standing Committee on the Law of Patents (SCP 21): Intervention of Pakistan on Opposition Systems

On Tuesday, 5 November 2014, Pakistan delivered the following intervention on opposition systems.

Mr. Chairman,

The agenda item on quality of patents also include another item on "opposition systems" which was not discussed by the Committee. I want to make a small statement on opposition systems.

WIPO patent committee (SCP21) to discuss International Nonproprietary Names and Exceptions and Limitations to Patent Rights

In the words of the International Bureau of the World Intellectual Property Organization (WIPO), the WIPO Standing Committee on the Law of Patents (SCP) was created,

created in 1998 to serve as a forum to discuss issues, facilitate coordination and provide guidance concerning the progressive international development of patent law.

WTO TRIPS Council (October 2014): Statement of India on the Review of the Paragraph 6 system (compulsory licensing for export)

On 28 October 2014, India delivered the following intervention at the WTO TRIPS Council's annual review of the Paragraph 6 system (designed to facilitate compulsory licensing for export of pharmaceuticals).

In particular, India noted that

Obama officials seek end of WIPO program on limitations and exceptions to patent rights in developing countries

During the WIPO 2014 General Assembly's discussions of patents and health in the context of the work of the Standing Committee on the Law of Patent (SCP), the Obama Administration embraced an aggressive position against WIPO technical assistance on the use of patent limitations and exceptions.

hamamoto_lee_22sep2014_wipoga.jpg

India's Department of Industrial Policy and Promotion creates IPR Think Tank to Draft National IPR Policy

On Friday, 24 October 2014, India's Department of Industrial Policy and Promotion (DIPP) announced the creation of an IPR Think Tank to Draft National Intellectual Property Rights Policy.

The composition of the think tank follows:

Justice Prabha Sridevan, Chairperson, IPR Think Tank;
Ms. Pratibha Singh, Advocate, Singh & Singh Associates, Member;
Ms. Punita Bhargava, Advocate, Inventure IP, Member;
Dr. Unnat Pandit, Cadila Pharmaceuticals Limited, Member;

Rajasingh on India-US dispute over patents on dasatinib, a drug to treat leukemia

link to video: https://www.youtube.com/watch?v=vU-JLDq02CE See also: http://keionline.org/node/2109.

Video script:

My name is Elizabeth Rajasingh.

I want to talk about a trade dispute between India and the United States, involving patents on a drug for leukemia.

Comments to USTR on the Out-of-Cycle Review for India due October 31, 2014.

michael_froman.png
Ambassador Michael Froman wants to block compulsory licenses on drug patents in India

New leak of TPP consolidated text on intellectual property provides details of pandering to drug companies and publishers

For more information:
James Love, Knowledge Ecology International
email: james.love@keionline.org, +1.202.361.3040

The May 16, 2014 version of the consolidated negotiating text for the Intellectual Property Chapter for the Trans-Pacific Partnership (TPP) agreement is a long, complex document that taken as a whole is designed to expand and extend monopolies on knowledge goods, including in particular publisher-owned copyrights, patents on inventions, and monopoly rights in data used to register new drugs, vaccines and agricultural chemical products.

UPDATE: TRIPS Council (Oct. 2014): Ukraine requests discussion on compatibility of tobacco plain packaging measures with TRIPS

UPDATE: On 17 October 2014, the Secretariat of the World Trade Organization (WTO) circulated an updated WTO airgram WTO/AIR/4358 REV. 1 to its Members following a request by Ukraine. Ukraine requested the addition of an item on "Concerns with Respect to Measures Related to Plain Packaging of Tobacco Products and their Compatibility with the TRIPS Agreement." This will be discussed under agenda item 13.

What PhRMA Wants from TTIP

What PhRMA Wants from TTIP Oct 1, 2014
From the TTIP Stakeholder Forum.

KEI Notes & Comments at TTIP Seventh Round of Negotiations at Stakeholder Event

The 7th Round of the negotiations of the Transatlantic Trade and Investment Partnership (TTIP) Agreement began Monday September 29, 2014 in the United States. This round's paltry effort at transparency, the TTIP Stakeholder Engagement Day, was held at the suburban 4-H conference center in Chevy Chase, MD. Although the information packet for the event included public transport instructions, the location was difficult to access for any attendees without a car, and even then, parking was extremely limited.

Matrix of Export Possibilities under Gilead HCV Licence

KEI was asked to make a presentation on Hepatitis C, on September 30, 2014, at a lunch seminar at UNITAID. I am attaching a PDF of the slides I used, as well as an eight page memo that takes a look at the recent Gilead license. The memo on the license was last edited on September 30, 2014, and is presented as a draft that may be revised in the future.

WIPO General Assembly: Worst ever?

brazilIMG_20140930_234549887_1024.jpg
Brazil asks delegates to embrace work on copyright exceptions
Syndicate content